Bg pattern

DUPHALAC 667 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DUPHALAC 667 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information: Summary of Product Characteristics

Duphalac 667 mg/ml Oral Solution

Lactulose

Read this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Pack

  1. What is Duphalac and what is it used for
  2. Before you take Duphalac
  3. How to take Duphalac
  4. Possible side effects
  5. Storage of Duphalac
  6. Contents of the pack and further information

1. What is Duphalac and what is it used for

Duphalac contains a laxative called lactulose, which works by softening the stools to improve transit and defecation, pushing water into the intestine. It is not absorbed by the body.

Duphalac is used to treat constipation (infrequent bowel movements, hard and dry stools) to produce semi-solid stools. It is used, for example, when there are hemorrhoids, in anal surgery, or in surgery on the lower part of the intestine. Additionally, it is used to treat and prevent hepatic encephalopathy (a liver disease that causes difficulty thinking, tremors, decreased consciousness, and even coma).

You should consult a doctor if your symptoms worsen or do not improve after several days of treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before you take Duphalac

Do not take Duphalac:

  • If you are allergic to lactulose or any of the other ingredients of this medicine (listed in section 6).
  • If you have galactosemia (a serious genetic disorder that prevents the digestion of galactose).
  • If you have a gastrointestinal obstruction, perforation, or risk of perforation (apart from habitual constipation).

If you have any doubts, consult your doctor or pharmacist.

Warnings and Precautions

Consult your doctor, pharmacist, or nurse before starting to take Duphalac.

This medicine contains lactose, galactose, and fructose from the manufacturing process. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

This medicine may contain sulfites from the manufacturing process. Rarely, it can cause severe hypersensitivity reactions and bronchospasm.

It is advisable to consult your doctor in the following cases:

  • If you present with symptoms of abdominal pain of unknown cause before starting treatment.
  • If, after several days of treatment, the effect of the medicine is insufficient.
  • If you are lactose intolerant.
  • If you are diabetic.

If you are diabetic and are being treated for hepatic encephalopathy, your dose of Duphalac will be higher. This amount of Duphalac contains a large amount of sugar, so you will need to adjust the dose of your antidiabetic treatment.

  • Chronic use of unadjusted doses of Duphalac (exceeding 2-3 semi-solid bowel movements per day) or misuse can lead to diarrhea and electrolyte imbalance.

Do not use Duphalac without medical supervision for more than two weeks.

You should be aware that the defecation reflex may deteriorate during treatment.

Children

Duphalac should not be given frequently to babies and children, as it can cause alterations in normal defecation reflexes.

In special conditions, your doctor may prescribe it for babies or children. In those cases, your doctor will closely monitor the treatment.

Using Duphalac with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

It is not advisable to use the following medicines with Duphalac:

  • Mesalazine (intestinal anti-inflammatory): as it may decrease the effect of mesalazine.
  • Antacids (reduce stomach pH): as it may alter the action of Duphalac.
  • Diuretics (promote urine elimination): as it may increase potassium loss.
  • Corticosteroids (used, for example, in inflammatory processes, immune disorders, etc.): as it may increase potassium loss.
  • Amphotericin B (antibiotic): as it may increase potassium loss.
  • Cardiac glycosides (medicines for heart disorders): Duphalac may increase the effect of cardiac glycosides if there is a decrease in potassium levels.

Using Duphalac with food, drinks, and alcohol

Duphalac can be taken with or without food. There are no restrictions on what you can eat or drink with Duphalac.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Duphalaccan be taken during pregnancy and breastfeeding.

No effects of Duphalac on fertility are expected.

Driving and Using Machines

This medicine does not affect your ability to drive or use machines.

3. How to take Duphalac

Oral use.

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

To facilitate the dosing of this medicine, the following equivalences should be taken into account. One tablespoon contains 15 ml of oral solution. One dessert spoon contains 5 ml of oral solution.

The dose should be assessed based on the clinical response. The duration of treatment should be adapted according to symptoms.

Lactulose can be administered in a single daily dose or divided into two doses. In the case of a single daily dose, it should be taken always at the same time, for example, during breakfast.

The corresponding dose of the oral solution can be taken diluted with liquids or undiluted, swallowing it quickly without keeping it in the mouth.

During treatment with laxatives, such as Duphalac, you should drink a sufficient amount of liquids (approximately 1.5 - 2 liters daily, equivalent to 6 - 8 glasses).

Adults

Dosing for Constipation or when Softening of the Stools is Necessary

The initial dose should be administered once a day, for example, during breakfast, or divided into two doses per day.

The maintenance dose should be adjusted after a few days, based on the response to treatment, which requires several days (2-3).

Initial Daily Dose

Maintenance Daily Dose

Adults

10 – 30 g (corresponding to 15 - 45 ml/day of oral solution)

10 – 20 g (corresponding to 15 - 30 ml/day of oral solution)

Dosing for Hepatic Encephalopathy

The recommended initial dose is 20 - 30 g, which corresponds to 30 - 45 ml, equivalent to 2 - 3 tablespoons, administered three to four times a day.

The maintenance dose will be adjusted to achieve two or three semi-solid bowel movements per day.

Special Populations

Renal and Hepatic Impairment

No dose adjustment is necessary in this group of patients.

Elderly Patients

No dose adjustment is necessary in this group of patients since the systemic exposure to lactulose is insignificant.

If you take more Duphalac than you should

In case you have taken more Duphalac than you should, you may experience diarrhea, abdominal pain, and electrolyte loss. In this case, stop the treatment with Duphalac and consult your doctor for appropriate treatment of your symptoms.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91.562.04.20, indicating the medicine and the amount ingested.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

If you forget to take Duphalac

If you forget to take a dose, take it as soon as you remember and continue with the normal treatment. Do not take a double dose to make up for forgotten doses.

If you stop taking Duphalac

Do not stop the treatment or discontinue it without consulting your doctor.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported:

  • Especially during the first few days of treatment: flatulence (gas), which usually disappears after a few days.
  • When taking a higher dose than recommended: abdominal pain and diarrhea. In these cases, the dose should be reduced.

If lactulose is administered at high doses (usually only associated with hepatic encephalopathy) or for a prolonged period, the patient may experience an electrolyte imbalance (minerals present in the blood and other body fluids) due to diarrhea.

In clinical trials of patients treated with lactulose, the following side effects have been found:

Gastrointestinal disorders: very common (may affect more than 1 in 10 patients): diarrhea; common (may affect up to 1 in 10 patients): flatulence, abdominal pain, nausea, and vomiting. Laboratory tests: uncommon (may affect up to 1 in 100 patients): electrolyte imbalance due to diarrhea.

-Immune system disorders: frequency not known (cannot be estimated from the available data): allergic reactions

-Skin and subcutaneous tissue disorders: frequency not known (cannot be estimated from the available data): rash, pruritus, urticaria.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Duphalac

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month.

Do not store above 25°C. Even in the recommended storage conditions, the color may darken, which is characteristic of sugar solutions and does not affect the therapeutic action.

Store in the original package, tightly closed.

Do not freeze. If frozen, the characteristics of the solution may change, becoming almost solid, although it returns to its normal consistency when left at room temperature.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Duphalac

  • The active substance is lactulose. 1 ml of Duphalac oral solution contains 667 mg of lactulose.

Appearance and pack size

Duphalac oral solution is a clear, viscous, colorless or light brown liquid.

It is available in plastic bottles with a screw cap, sealed, white, of 200 ml and 800 ml.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Cooper Consumer Health B.V.

Verrijn Stuartweg 60,

1112 AX Diemen,

Netherlands

Manufacturer:

Abbott Biologicals B.V.

Veerweg 12, Olst, Netherlands

For further information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Vemedia Pharma Hispania, S.A.

C/ Aragón, 182, 5ª planta

08011 – Barcelona

Spain

Date of last revision of this leaflet: April 2024

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.es/

Online doctors for DUPHALAC 667 mg/ml ORAL SOLUTION

Discuss questions about DUPHALAC 667 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for DUPHALAC 667 mg/ml ORAL SOLUTION?
DUPHALAC 667 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in DUPHALAC 667 mg/ml ORAL SOLUTION?
The active ingredient in DUPHALAC 667 mg/ml ORAL SOLUTION is lactulose. This information helps identify medicines with the same composition but different brand names.
How much does DUPHALAC 667 mg/ml ORAL SOLUTION cost in pharmacies?
The average pharmacy price for DUPHALAC 667 mg/ml ORAL SOLUTION is around 4.78 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures DUPHALAC 667 mg/ml ORAL SOLUTION?
DUPHALAC 667 mg/ml ORAL SOLUTION is manufactured by Cooper Consumer Health B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of DUPHALAC 667 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether DUPHALAC 667 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to DUPHALAC 667 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (lactulose) include DUPHALAC 10 G ORAL SOLUTION IN SACHET, LACTULOSE LAINCO 10 g ORAL SOLUTION IN SACHETS, LACTULOSE LAINCO 3.33 g/5 ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media